APA (7th ed.) Citation

Wang, H., Li, J., Zhu, X., Wang, R., & Wan, Y. (2025). A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-85831-4

Chicago Style (17th ed.) Citation

Wang, Huaxiang, Junjun Li, Xiuling Zhu, Ruling Wang, and Yunyan Wan. "A Real-world Drug Safety Surveillance Study from the FAERS Database of Hepatocellular Carcinoma Patients Receiving Pembrolizumab Alone and Plus Lenvatinib." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-85831-4.

MLA (9th ed.) Citation

Wang, Huaxiang, et al. "A Real-world Drug Safety Surveillance Study from the FAERS Database of Hepatocellular Carcinoma Patients Receiving Pembrolizumab Alone and Plus Lenvatinib." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-85831-4.